November 24, 2025 | 3rd Party Submission
Patent application: 5-MeO-DMT for treatment of Postpartum Depression (PPD)
View Press ReleaseNovember 24, 2025 | 3rd Party Submission
Patent application: therapeutic use of 5-MeO-DMT for treatment of postnatal depression
View Press ReleaseNovember 21, 2025 | 3rd Party Submission
Patent application: non-racemic formulations of R- and S-MDMA
View Press ReleaseNovember 20, 2025 | 3rd Party Submission
Patent application: 5-MeO-DMT for treatment of Postpartum Depression (PPD)
View Press ReleaseNovember 20, 2025 | 3rd Party Submission
Patent application: 5-MeO-DMT for the treatment of Postpartum Depression (PPD)
View Press ReleaseNovember 14, 2025 | 3rd Party Submission
Patent application: 5-MeO-DMT for treatment of Postpartum Depression (PPD)
View Press ReleaseNovember 14, 2025 | 3rd Party Submission
Patent application: plant formulations for pulmonary delivery
View Press ReleaseNovember 13, 2025 | 3rd Party Submission
Patent application: intranasal 5-MeO-DMT dry powder for treatment of disorders
View Press ReleaseNovember 10, 2025 | 3rd Party Submission
Patent application: a crystalline polymorph of psilocybin hydrate
View Press ReleaseView Our Summary Chart